Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.

Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions.

Aragon-Ching JB, Werntz RP, Zietman AL, Steinberg GD.

Am Soc Clin Oncol Educ Book. 2018 May 23;(38):307-318. doi: 10.1200/EDBK_201227.

2.

Red Journal Readers' Top Articles From 2017.

Yom SS, Zietman AL.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1011-1013. doi: 10.1016/j.ijrobp.2018.05.047. No abstract available.

PMID:
30012519
3.

Impact of interfractional motion on hypofractionated pencil beam scanning proton therapy and VMAT delivery for prostate cancer.

Moteabbed M, Trofimov A, Khan FH, Wang Y, Sharp GC, Zietman AL, Efstathiou JA, Lu HM.

Med Phys. 2018 Jul 14. doi: 10.1002/mp.13091. [Epub ahead of print]

PMID:
30007067
4.

Radiation Therapy Research: A Global Analysis 2001-2015.

Aggarwal A, Lewison G, Rodin D, Zietman A, Sullivan R, Lievens Y.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):767-778. doi: 10.1016/j.ijrobp.2018.03.009. Epub 2018 Mar 20. Review.

5.

Radiation Therapy in a Time of Disaster.

Yom SS, Zietman AL.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):832-833. doi: 10.1016/j.ijrobp.2017.12.001. No abstract available.

PMID:
29485054
6.

The Red Journal's Top Downloads of 2016.

Zietman AL.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):254-256. doi: 10.1016/j.ijrobp.2018.01.090. Epub 2018 Feb 14. No abstract available.

PMID:
29454713
7.

Radiation oncology authors and reviewers prefer double-blind peer review.

Bennett KE, Jagsi R, Zietman A.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E1940. doi: 10.1073/pnas.1721225115. Epub 2018 Feb 6. No abstract available.

8.

Clinical needs assessment for sexual health among cancer patients receiving pelvic radiation: Implications for development of a radiation oncology sexual health clinic.

Wo JY, Drapek LC, Niemierko A, Silvia B, Noé BN, Russo AL, Miyamoto DT, Hong TS, Efstathiou JA, Zietman AL, Dizon DS.

Pract Radiat Oncol. 2018 May - Jun;8(3):206-212. doi: 10.1016/j.prro.2017.11.004. Epub 2017 Nov 21.

PMID:
29426693
9.

Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.

Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA.

JAMA Oncol. 2018 May 10;4(5):e175230. doi: 10.1001/jamaoncol.2017.5230. Epub 2018 May 10.

PMID:
29372236
10.

Too Big to Fail? The Current Status of Proton Therapy in the USA.

Zietman AL.

Clin Oncol (R Coll Radiol). 2018 May;30(5):271-273. doi: 10.1016/j.clon.2017.11.002. Epub 2017 Nov 24. No abstract available.

PMID:
29239732
11.

Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.

Ramey SJ, Agrawal S, Abramowitz MC, Moghanaki D, Pisansky TM, Efstathiou JA, Michalski JM, Spratt DE, Hearn JWD, Koontz BF, Liauw SL, Pollack A, Anscher MS, Den RB, Stephans KL, Zietman AL, Lee WR, Stephenson AJ, Tendulkar RD.

Eur Urol. 2018 Jul;74(1):99-106. doi: 10.1016/j.eururo.2017.10.009. Epub 2017 Nov 9.

PMID:
29128208
12.

In Reply to Tokuuye.

Zietman A.

Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):503. doi: 10.1016/j.ijrobp.2017.08.019. No abstract available.

PMID:
28872007
13.

The Ethics of Scientific Publishing: Black, White, and "Fifty Shades of Gray".

Zietman AL.

Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):275-279. doi: 10.1016/j.ijrobp.2017.06.009. No abstract available.

PMID:
28871970
14.

Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer.

Sanchez A, Wszolek MF, Niemierko A, Clayman RH, Drumm M, Rodríguez D, Feldman AS, Dahl DM, Heney NM, Shipley WU, Zietman AL, Efstathiou JA.

J Urol. 2018 Feb;199(2):407-415. doi: 10.1016/j.juro.2017.08.106. Epub 2017 Sep 1.

PMID:
28870862
15.

Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience.

Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA.

Clin Genitourin Cancer. 2017 Aug 3. pii: S1558-7673(17)30236-7. doi: 10.1016/j.clgc.2017.07.026. [Epub ahead of print]

PMID:
28864223
16.

Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.

Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM.

J Oncol Pract. 2017 Sep;13(9):621-625. doi: 10.1200/JOP.2017.024919. Epub 2017 Aug 10. No abstract available.

PMID:
28796558
17.

Frailty is our Destiny: An Introduction to the Red Journal's Special Edition on Radiation Therapy in the Elderly.

Zietman AL.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):713-714. doi: 10.1016/j.ijrobp.2017.05.015. No abstract available.

PMID:
28602404
18.

Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.

Jang JW, Drumm MR, Efstathiou JA, Paly JJ, Niemierko A, Ancukiewicz M, Talcott JA, Clark JA, Zietman AL.

Cancer Med. 2017 Jul;6(7):1827-1836. doi: 10.1002/cam4.1103. Epub 2017 May 31.

19.

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM.

J Urol. 2017 Sep;198(3):552-559. doi: 10.1016/j.juro.2017.04.086. Epub 2017 Apr 26.

20.

Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early-stage prostate cancer.

Xiang HF, Lu HM, Efstathiou JA, Zietman AL, De Armas R, Harris K, Bloch BN, Qureshi MM, Keohan S, Hirsch AE.

J Appl Clin Med Phys. 2017 May;18(3):37-43. doi: 10.1002/acm2.12063. Epub 2017 Apr 13.

21.

Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience.

Buscariollo DL, Drumm M, Niemierko A, Clayman RH, Galland-Girodet S, Rodin D, Feldman AS, M Dahl D, McGovern FJ, F Olumi A, Eidelman A, Shipley WU, Zietman AL, Efstathiou JA.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):e125-e133. doi: 10.1016/j.prro.2016.10.010. Epub 2016 Oct 19.

PMID:
28274403
22.

Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.

Gandaglia G, Briganti A, Clarke N, Karnes RJ, Graefen M, Ost P, Zietman AL, Roach M 3rd.

Eur Urol. 2017 Nov;72(5):689-709. doi: 10.1016/j.eururo.2017.01.039. Epub 2017 Feb 8. Review.

PMID:
28189428
23.

Proton therapy of prostate cancer by anterior-oblique beams: implications of setup and anatomy variations.

Moteabbed M, Trofimov A, Sharp GC, Wang Y, Zietman AL, Efstathiou JA, Lu HM.

Phys Med Biol. 2017 Mar 7;62(5):1644-1660. doi: 10.1088/1361-6560/62/5/1644. Epub 2017 Feb 6.

PMID:
28166057
24.

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

Shipley WU, Seiferheld W, Lukka HR, Major PP, Heney NM, Grignon DJ, Sartor O, Patel MP, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Lawton CA, Feng FY, Lovett RD, Balogh AG, Souhami L, Rosenthal SA, Kerlin KJ, Dignam JJ, Pugh SL, Sandler HM; NRG Oncology RTOG.

N Engl J Med. 2017 Feb 2;376(5):417-428. doi: 10.1056/NEJMoa1607529.

25.

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.

Giacalone NJ, Shipley WU, Clayman RH, Niemierko A, Drumm M, Heney NM, Michaelson MD, Lee RJ, Saylor PJ, Wszolek MF, Feldman AS, Dahl DM, Zietman AL, Efstathiou JA.

Eur Urol. 2017 Jun;71(6):952-960. doi: 10.1016/j.eururo.2016.12.020. Epub 2017 Jan 9.

PMID:
28081860
26.

Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.

Underwood TS, Voog JC, Moteabbed M, Tang S, Soffen E, Cahlon O, Lu HM, Zietman AL, Efstathiou JA, Paganetti H.

Acta Oncol. 2017 Apr;56(4):575-581. doi: 10.1080/0284186X.2016.1275781. Epub 2017 Jan 11.

PMID:
28075206
27.

Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy.

Krasnow RE, Drumm M, Roberts HJ, Niemierko A, Wu CL, Wu S, Zhang J, Heney NM, Wszolek MF, Blute ML, Feldman AS, Lee RJ, Zietman AL, Shipley WU, Efstathiou JA.

Eur Urol. 2017 Jul;72(1):54-60. doi: 10.1016/j.eururo.2016.12.002. Epub 2016 Dec 28.

PMID:
28040351
28.

Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.

Smith GL, Ganz PA, Bekelman JE, Chmura SJ, Dignam JJ, Efstathiou JA, Jagsi R, Johnstone PA, Steinberg ML, Williams SB, Yu JB, Zietman AL, Weichselbaum RR, Tina Shih YC.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):450-461. doi: 10.1016/j.ijrobp.2016.10.042. Epub 2016 Nov 8.

29.

Introducing: The Red Journal Gray Zone.

Palma DA, Yom SS, Bennett KE, Corry J, Zietman AL.

Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):1. doi: 10.1016/j.ijrobp.2016.11.052. No abstract available.

PMID:
27979440
30.

In Reply to Samaratunga et al.

Zietman A, Smith J, Klein E, Droller M, Dasgupta P, Catto J.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1127-1128. doi: 10.1016/j.ijrobp.2016.08.027. No abstract available.

PMID:
27869088
31.

Painting Dose: The ART of Radiation.

Roberts HJ, Zietman AL, Efstathiou JA.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):722-728. doi: 10.1016/j.ijrobp.2016.08.010. Epub 2016 Aug 20. Review.

PMID:
27788945
32.

Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding.

Lee JY, Daignault-Newton S, Heath G, Scarlett S, Sanda MG, Chang P, Regan MM, Michalski JM, Sandler HM, Feng FY, Kuban DA, Zietman AL, Ciezki JP, Kaplan ID, Crociani C, McLaughlin WP, Mantz CA, Finkelstein SE, Suy S, Collins SP, Garin O, Ferrer M, Hamstra DA, Spratt DE.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):770-777. doi: 10.1016/j.ijrobp.2016.07.038. Epub 2016 Aug 3.

PMID:
27663760
33.

Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.

Pisansky TM, Agrawal S, Hamstra DA, Koontz BF, Liauw SL, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ, Tendulkar RD.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1046-1053. doi: 10.1016/j.ijrobp.2016.08.043. Epub 2016 Sep 3.

PMID:
27745980
34.

Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.

Mak KS, Smith AB, Eidelman A, Clayman R, Niemierko A, Cheng JS, Matthews J, Drumm MR, Nielsen ME, Feldman AS, Lee RJ, Zietman AL, Chen RC, Shipley WU, Milowsky MI, Efstathiou JA.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1028-1036. doi: 10.1016/j.ijrobp.2016.08.023. Epub 2016 Aug 24.

PMID:
27727064
35.

The American Board of Radiology radiation oncology Maintenance of Certification Part 3 Modular Examination: Evaluation of the first administration.

Wallner PE, Gerdeman A, Willis JM, Zietman AL.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):436-438. doi: 10.1016/j.prro.2016.04.007. Epub 2016 May 7.

PMID:
27687188
36.

The Radiation Oncology Job Market: The Economics and Policy of Workforce Regulation.

Falit BP, Pan HY, Smith BD, Alexander BM, Zietman AL.

Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):501-10. doi: 10.1016/j.ijrobp.2016.05.029. Epub 2016 Jun 8. Review.

PMID:
27681745
37.

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.

Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ.

J Clin Oncol. 2016 Oct 20;34(30):3648-3654. doi: 10.1200/JCO.2016.67.9647.

PMID:
27528718
38.

Consensus guidelines for reporting prostate cancer Gleason Grade.

Egevad L, Samaratunga H, Srigley JR, Delahunt B, Zietman A, Smith J, Klein E, Droller M, Dasgupta P, Catto J.

BJU Int. 2016 Sep;118(3):E1-2. doi: 10.1111/bju.13596. No abstract available.

40.

Re: Samaratunga et al: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade.

Klein EA, Smith JA, Zietman AL, Dasgupta P, Catto J, Droller M, Millar S.

Urology. 2016 Oct;96:179. doi: 10.1016/j.urology.2016.07.005. Epub 2016 Jul 18. No abstract available.

PMID:
27443466
41.

Editorial Statement on Gleason Scoring for Prostate Cancer.

Zietman AL, Smith J, Klein E, Droller M, Dasgupta P, Catto J.

Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1092. doi: 10.1016/j.ijrobp.2016.02.055. Epub 2016 Mar 3. No abstract available.

PMID:
27354124
42.

The Red Journal's Top Downloads of 2015.

Zietman AL.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):861-863. doi: 10.1016/j.ijrobp.2016.02.047. No abstract available.

PMID:
27302501
43.

Prostatectomy vs radiation therapy for prostate cancer: The (still) unsolved dilemma.

De Bari B, Zietman AL, Poortmans P.

Radiother Oncol. 2016 May;119(2):368. doi: 10.1016/j.radonc.2016.03.026. Epub 2016 Jun 4. No abstract available.

PMID:
27267818
44.

Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee.

Turner EL, Metcalfe C, Donovan JL, Noble S, Sterne JA, Lane JA, I Walsh E, Hill EM, Down L, Ben-Shlomo Y, Oliver SE, Evans S, Brindle P, Williams NJ, Hughes LJ, Davies CF, Ng SY, Neal DE, Hamdy FC, Albertsen P, Reid CM, Oxley J, McFarlane J, Robinson MC, Adolfsson J, Zietman A, Baum M, Koupparis A, Martin RM.

Br J Cancer. 2016 Jun 28;115(1):90-4. doi: 10.1038/bjc.2016.162. Epub 2016 Jun 2.

45.

International Medical Graduates in Radiation Oncology: Historical Trends and Comparison With Other Medical Specialties.

Verma V, Shah C, Lautenschlaeger T, Lin C, Beriwal S, Zhen W, Mehta MP, Zietman AL.

Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1102-6. doi: 10.1016/j.ijrobp.2016.03.008. Epub 2016 Mar 18.

PMID:
27209507
46.

Consensus guidelines for reporting prostate cancer Gleason Grade.

Zietman A, Smith J, Klein E, Droller M, Dasgupta P, Catto J.

BJU Int. 2016 Jun;117(6):849. doi: 10.1111/bju.13470. No abstract available.

47.

New Gleason grading system: Statement from the Editors of six journals.

Zietman A, Smith J, Klein E, Droller MJ, Dasgupta P, Catto J.

Urol Oncol. 2016 Jun;34(6):253. doi: 10.1016/j.urolonc.2016.03.016. Epub 2016 May 4. No abstract available.

PMID:
27155915
48.

Making Radiation Therapy for Prostate Cancer More Economical and More Convenient.

Zietman AL.

J Clin Oncol. 2016 Jul 10;34(20):2323-4. doi: 10.1200/JCO.2016.67.3764. Epub 2016 Apr 18. No abstract available.

PMID:
27091711
49.

Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.

Underwood T, Giantsoudi D, Moteabbed M, Zietman A, Efstathiou J, Paganetti H, Lu HM.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):454-64. doi: 10.1016/j.ijrobp.2016.01.018. Epub 2016 Jan 19.

PMID:
27084660
50.

Particle Therapy at the "Tipping Point": An Introduction to the Red Journal's Special Edition.

Zietman AL.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):1-3. doi: 10.1016/j.ijrobp.2016.02.056. No abstract available.

PMID:
27084615

Supplemental Content

Loading ...
Support Center